Cited by 79Neurotransmitter Receptor Influence on BehaviorNicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation

Pharmacological manipulations of the pedunculopontine tegmental nucleus in the rat reduce self-administration of both nicotine and cocaine

Corrigall, William, Coen, Kathleen, Zhang, Jianhua, Adamson, Laurel·2002·Psychopharmacology

Abstract

Rationale The pedunculopontine tegmental nucleus (PPTg) has been implicated in the self-administration of drugs, particularly nicotine, which acts directly through the PPTg in addition to targeting midbrain dopamine neurons. The direct action of nicotine in PPTg may be through GABAergic mechanisms that have been shown to influence nicotine self-administration preferentially compared to cocaine.Objective The purpose of these experiments was to examine several pharmacological manipulations that alter neuronal activity in the PPTg for their specificity or generality in nicotine versus cocaine reinforcement.Methods and results Rats trained to self-administer nicotine or cocaine intravenously were prepared with brain microcannulae directed to the PPTg. Intra-PPTg microinfusions of the muscarinic agonist carbachol (0.1-1.0 microg), the micro opioid agonist DAMGO (0.005 and 0.05 microg), tetrodotoxin (5 ng) and neostigmine (0.5 nmol) each reduced the self-administration of nicotine and cocaine maintained on an FR5 schedule of reinforcement. The muscarinic antagonist scopolamine (0.1-1.0 microg) and the opioid antagonist CTOP (1 microg) did not affect self-administration, but reversed the effects of the respective agonist when co-administered with it. Carbachol and DAMGO were also tested in self-administration maintained on a progressive-ratio schedule; each agonist again reduced both nicotine and cocaine self-administration.Conclusions PPTg manipulations are able to alter established self-administration of nicotine, which acts at the level of the ventral tegmental area and the PPTg itself, and cocaine, which acts through the mesolimbic dopamine system. These data suggest that the PPTg is an important substrate in drug dependence.

Integrity signals

Registry

Crossref · 10.1007/s00213-001-0965-2

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Stimulation of nicotinic receptors and M5-type muscarinic receptors increases the tonic excitability of dopamine neurons.

    “Stimulation of nAChR and M5-type mAChRs increases the tonic excitability of these DA neurons (Corrigall et al., 2002; Miller and Blaha, 2005; Yeomans and Baptista, 1997).”
  • Disruption of PPTg activity decreases the rewarding and locomotor effects of drugs of abuse such as cocaine and nicotine.

    “At the behavioral level, this conclusion is consistent with the finding that disruption of PPTg activity decreases the rewarding and locomotor effects of drugs of abuse such as cocaine and nicotine (Champtiaux et al., 2006; Corrigall et al., 1994; Corrigall et al., 2002), while lesion of NAc cholinergic neurons increases cocaine self-administration, as might be expected if a pause in cholinergic”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Corrigall, W., Coen, K., Zhang, J., & Adamson, L.
Affiliations
  • University of Toronto (CA)
  • Centre for Addiction and Mental Health (CA)
Venue
Psychopharmacology
Published
2002-03-01
Volume
160
Issue
2
Pages
198-205
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2064322520
Cited by
79
References
9
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 1 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 6 · 2013: 3 · 2012: 4
FWCI
1.75
Type
journal article
Language
en
Open access
closed
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01da009577-06)
  • National Institute on Drug Abuse (DA 09577)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
Keywords
pedunculopontine nucleus, nicotine self-administration, cocaine self-administration, drug reinforcement, carbachol, muscarinic agonists, DAMGO, opioid agonists, tetrodotoxin, neostigmine, scopolamine, CTOP, GABAergic mechanisms, mesolimbic dopamine system, ventral tegmental area, drug addiction, progressive ratio schedule
MeSH terms
Animals, Behavior, Animal, Carbachol, Central Nervous System Agents, Cocaine, Male, Nicotine, Scopolamine, Self Administration, Tegmentum Mesencephali, Substance-Related Disorders, Rats, Long-Evans, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review